VAERS reports by lot

Merck Pneumococcal lot U035117: VAERS reports

36 VAERS reports list lot U035117 as a Merck Pneumococcal vaccine, received between 2022-06-14 and 2024-06-17. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
36
Reports
3%
Marked serious
0
With a death outcome
18
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Cardiac / Cardiovascular3222%
Injection-site / Local reaction2718%
General / Systemic (non-local)2618%
Thrombotic / Hematological1410%
Musculoskeletal117%
Dermatological (non-injection-site)117%
Allergic / Anaphylactic96%
Gastrointestinal75%
Neurological53%
Respiratory43%
Psychiatric / Neuropsychiatric11%

Where reports came from

U.S. state of the reporter, where given (top 12).

Illinois5
Florida4
North Carolina4
Texas3
Washington3
Maryland3
South Carolina2
Ohio1
Georgia1
Connecticut1
Hawaii1
Michigan1

Reports by month received

2022-061
2022-073
2022-087
2022-093
2022-101
2022-111
2022-121
2023-011
2023-022
2023-031
2023-052
2023-071
2023-081
2023-095
2023-102
2023-112
2024-031
2024-061

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.